Robert Shawah
CFO
CFO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Acurx Pharmaceuticals, Inc. (ACXP) | Chief Financial Officer | $395,840 | $907,463 |
| 2023 | Acurx Pharmaceuticals, Inc. (ACXP) | Chief Financial Officer | $375,000 | $675,038 |
| 2022 | Acurx Pharmaceuticals, Inc. (ACXP) | Chief Financial Officer | $300,000 | $375,000 |
| 2021 | Acurx Pharmaceuticals, Inc. (ACXP) | Chief Financial Officer | $170,050 | $1,462,738 |
| 2020 | Acurx Pharmaceuticals, Inc. (ACXP) | Chief Financial Officer | $90,000 | $152,500 |
Earnings-call appearances
-
Acurx Pharmaceuticals, Inc. Q3 FY2025 Earnings Call2025-09-30
Acurx Pharmaceuticals, Inc. (ACXP)
-
Acurx Pharmaceuticals, Inc. Q2 FY2025 Earnings Call2025-06-30
Acurx Pharmaceuticals, Inc. (ACXP)
-
Acurx Pharmaceuticals, Inc. Q1 FY2025 Earnings Call2025-05-13
Acurx Pharmaceuticals, Inc. (ACXP)
-
Acurx Pharmaceuticals, Inc. Q4 FY2024 Earnings Call2025-03-18
Acurx Pharmaceuticals, Inc. (ACXP)
-
Acurx Pharmaceuticals, Inc. Q3 FY2024 Earnings Call2024-11-13
Acurx Pharmaceuticals, Inc. (ACXP)
-
Acurx Pharmaceuticals, Inc. Q2 FY2024 Earnings Call2024-08-09
Acurx Pharmaceuticals, Inc. (ACXP)
-
Acurx Pharmaceuticals, Inc. Q1 FY2024 Earnings Call2024-05-15
Acurx Pharmaceuticals, Inc. (ACXP)
-
Acurx Pharmaceuticals, Inc. Q4 FY2023 Earnings Call2024-03-18
Acurx Pharmaceuticals, Inc. (ACXP)
-
Acurx Pharmaceuticals, Inc. Q3 FY2023 Earnings Call2023-11-14
Acurx Pharmaceuticals, Inc. (ACXP)
-
Acurx Pharmaceuticals, Inc. Q4 FY2022 Earnings Call2023-03-16
Acurx Pharmaceuticals, Inc. (ACXP)
-
Acurx Pharmaceuticals, Inc. Q3 FY2022 Earnings Call2022-11-14
Acurx Pharmaceuticals, Inc. (ACXP)
-
Acurx Pharmaceuticals, Inc. Q2 FY2022 Earnings Call2022-08-15
Acurx Pharmaceuticals, Inc. (ACXP)
-
Acurx Pharmaceuticals, Inc. Q3 FY2021 Earnings Call2021-11-16
Acurx Pharmaceuticals, Inc. (ACXP)